SANUWAVE Health, Inc.
SNWV • OTC
SANUWAVE Health, Inc. is a publicly traded company trading on OTC, led by CEO Morgan C. Frank.
CEOMorgan C. Frank
Next Earnings
Upcoming earnings announcement for SANUWAVE Health, Inc.
Date
Thursday, May 7, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.08
Revenue Estimate
$11.1M
Earnings History
Past 12 earnings reports for SANUWAVE Health, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | Q4 2025 | $0.03Est: $0.17 | -82.4% | $13.1MEst: $13.4M | -1.9% | — |
| Nov 6, 2025 | Q3 2025 | $0.46Est: $0.32 | +43.8% | $11.5MEst: $11.4M | +0.2% | — |
| Aug 7, 2025 | Q2 2025 | $0.01Est: -$0.09 | +111.1% | $10.2MEst: $10.1M | +0.2% | — |
| May 8, 2025 | Q1 2025 | -$0.66 | — | $9.3M | — | — |
| Mar 20, 2025 | Q4 2024 | -$1.11 | — | $10.3M | — | — |
| Nov 7, 2024 | Q3 2024 | -$6.49 | — | $9.4M | — | — |
| Aug 12, 2024 | Q2 2024 | $3.75 | — | $7.2M | — | — |
| May 9, 2024 | Q1 2024 | $0.00 | — | $5.8M | — | — |
| Mar 21, 2024 | Q4 2023 | $11.25 | — | $7.0M | — | — |
| Nov 10, 2023 | Q3 2023 | -$11.25 | — | $5.0M | — | — |
| Aug 11, 2023 | Q2 2023 | -$3.75 | — | $4.7M | — | — |
| May 12, 2023 | Q1 2023 | -$7.50 | — | $3.8M | — | — |